Vous êtes ici : Accueil > Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor

Essai publis

Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor

Publié le 6 octobre 2017
Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor
Description
 
Auteurs
Louveau B, Tost J, Mauger F, Sadoux A, Podgorniak MP, How-Kit A, Pages C, Roux J, Da Meda L, Lebbe C and Mourah S
Revue
Année2 017
Service
JACOB/CNRGH
Institut
 
Laboratoire
LEE
Date de création06/01/2017
Facteur Impact 

Retour à la liste